Cellnovo Stock

Stocks

CLNV

FR0012633360

Software

Real-time Euronext Paris 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Cellnovo -.--% -

Valuation: Cellnovo

Market Cap 2.44M 2.13M 1.96M 1.81M 3.42M 234M 3.48M 23.45M 9.2M 115M 9.15M 8.95M 395M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 10.89M 10.05M 9.24M 17.5M 1.2B 17.8M 120M 47.07M 586M 46.78M 45.76M 2.02B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
+2.62%-2.57% - - 20.64B
+2.21%+0.54%-32.48%+20.13% 16.32B
+1.71%+2.81%-49.79%-63.80% 7.76B
+10.01%+5.57%+14.26%+79.59% 7.51B
+5.25%+2.62%-24.88%+237.56% 4.31B
+3.42%+0.99%-36.91%-29.51% 2.29B
+2.97%+4.20%-35.50%-44.39% 1.75B
+0.25%-0.41%+4.00%+81.02% 1.51B
-0.53%-4.37%+3.06%+37.52% 1.44B
Average +2.59%-0.93%-19.78%+39.77% 6.35B
Weighted average by Cap. +3.11%-0.41%-24.55%+34.65%

Financials

2018 2019 *
Net sales 3.32M 2.9M 2.68M 2.46M 4.67M 320M 4.75M 31.99M 12.55M 156M 12.47M 12.2M 538M -
Net income -15.94M -13.94M -12.86M -11.82M -22.39M -1.53B -22.77M -153M -60.22M -750M -59.86M -58.55M -2.58B -
Net Debt 10.02M 8.76M 8.08M 7.43M 14.08M 964M 14.32M 96.5M 37.86M 471M 37.64M 36.81M 1.62B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock